• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Globus Medical Inc (NY: GMED )

    72.04 -0.01 (-0.01%)
    Streaming Delayed Price Updated: 12:46 PM EDT, Aug 26, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 180,495
    Open 72.00
    Bid (Size) 72.00 (2)
    Ask (Size) 72.08 (3)
    Prev. Close 72.05
    Today's Range 71.77 - 72.50
    52wk Range 43.38 - 74.21
    Shares Outstanding 135,407,017
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    GMED Investors Have Opportunity to Join Globus Medical, Inc. Securities Fraud Investigation with the Schall Law Firm
    From The Schall Law Firm
    Via Business Wire
    Globus Medical Launches ADIRA™ XLIF™ Plate System
    From Globus Medical
    Via GlobeNewswire

    Performance

    YTD
    +35.52%
    +35.52%
    1 Month
    +0.21%
    +0.21%
    3 Month
    +10.00%
    +10.00%
    6 Month
    +28.85%
    +28.85%
    1 Year
    +33.80%
    +33.80%

    More News

    Read More
    Investors should take note of NYSE:GMED, a growth stock that remains attractively priced.
    Via Chartmill
    GLOBUS ALERT: Bragar Eagel & Squire, P.C. is Investigating Globus Medical, Inc. on Behalf of Globus Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    Looking Into Globus Medical's Recent Short Interest
    Via Benzinga
    What 8 Analyst Ratings Have To Say About Globus Medical
    Via Benzinga
    Globus Medical, Inc. (GMED) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
    From Bronstein, Gewirtz & Grossman, LLC
    Via Business Wire
    Kirby McInerney LLP Announces Investigation of Shareholder Claims Against Globus Medical, Inc. (GMED)
    From Kirby McInerney LLP
    Via Business Wire
    Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
    From Glancy Prongay & Murray LLP
    Via Business Wire
    NYSE:GMED is showing decent growth, but is still valued reasonably.
    Via Chartmill
    Peering Into Globus Medical's Recent Short Interest
    Via Benzinga
    INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
    From Law Offices of Howard G. Smith
    Via Business Wire
    The Law Offices of Frank R. Cruz Announces Investigation of Globus Medical, Inc. (GMED) on Behalf of Investors
    From Law Offices of Frank R. Cruz
    Via Business Wire
    Globus Medical (GMED) Q2 2024 Earnings Call Transcript
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    GMED Stock Earnings: Globus Medical Beats EPS, Beats Revenue for Q2 2024
    Via InvestorPlace
    Where Globus Medical Stands With Analysts
    Via Benzinga
    NYSE:GMED is not too expensive for the growth it is showing.
    Via Chartmill
    Deep Dive Into Globus Medical Stock: Analyst Perspectives (7 Ratings)
    Via Benzinga
    Globus Medical Reports Second Quarter 2024 Results
    From Globus Medical
    Via GlobeNewswire
    Globus Medical Receives FDA 510(k) Clearance for ExcelsiusFlex™ and ACTIFY™ 3D Total Knee System
    From Globus Medical
    Via GlobeNewswire
    Globus Medical Schedules Second Quarter Earnings Release and Conference Call
    From Globus Medical
    Via GlobeNewswire
    For those who appreciate growth without the sticker shock, NYSE:GMED is worth considering.
    Via Chartmill
    Staar Surgical Stock Earns RS Rating Upgrade
    Via Investor's Business Daily
    Soft Inflation Data Boosts Small Caps, Real Estate, Regional Banks; Traders Anticipate Fed Rate Cuts As Stocks React
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Stryker Stock Sees RS Rating Treks Higher To 71
    Via Investor's Business Daily
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.